DDG Rapid Assessment of Infectious Diseases (RAID) Device

Disease Diagnostic Group (DDG)

The Rapid Assessment of Infectious Diseases (RAID) Device is a portable, reusable device that exploits the magnetic properties of disease biomarkers to detect diseases in less than 1 minute.

Data coming soon
Product description Brand name and product description

The Rapid Assessment of Infectious Diseases (RAID) Device is a prototype portable, reusable device that exploits the magnetic properties of biomarkers to detect infectious diseases in less than 1 minute. It can detect fever-like diseases such as dengue and upper respiratory infections such as pneumonia.

Target region(s) Target region for distribution/implementation (listed by country if specified)

South East Asia, primarily India and Singapore

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"

The device is distributed by regional partners including Bosch Healthcare and Denka.

Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.

500-1 000 USD for the device, per test cost is <0.25 USD Interview with designer, September 2020

Competitive landscape Similar products available on the market. May not be a comprehensive listing.

Tests used by trained medical professionals such as PCR, QBC, blood smear, or rapid diagnostic blood or urine tests.

SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Goal 3: Good health and well-being

Target user(s) Target user/consumer base (country, income segment)
The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F